BIOSTEMI Extended Survival: Orsiro DES Superior to Xience DES in STEMI Patients at 5 Years

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

~~$650.00 annually~~
$455.00 annually
Code: CRT30
Apply code at Checkout Offer Expires: May 31, 2025

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

BIOSTEMI Extended Survival: Orsiro DES Superior to Xience DES in STEMI Patients at 5 Years

Posted: 10/25/2023
Author:
Lior Lupu, MD, MBA, CRTonline.org
News

Percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) using biodegradable-polymer sirolimus-eluting stents (BP-SES) was found to be superior to durable-polymer everolimus-eluting stents (DP-EES) in the extended 5-year follow-up of the BIOSTEMI study.
1-3 of 4225 results
1 2 3 4 5 Next »

Worse Patient Outcomes, Higher Costs in Waiting to Perform AVR in Patients With AS: Database Study

May 22, 2025 by
Bailey G. Salimes, CRTonline.org

PARIS – Aortic valve replacement (AVR) is best performed before symptom onset to improve outcomes in patients with aortic stenosis (AS) and reduce healthcare costs, a new study shows.

Coronary Function Testing Safe, Effective, Improves Quality of Life in ANOCA Patients: ILIAS-ANOCA Trial

May 22, 2025 by
Bailey G. Salimes, CRTonline.org

PARIS – Patients with angina and non-obstructive coronary arteries (ANOCA) can be safely and feasibly given routine ad-hoc coronary function testing (CFT) during invasive coronary angiography (ICA), according to results from the ILIAS ANOCA trial.

Combined Registry Study Finds PCBs vs SCBs Demonstrate Similar 2-Year Outcomes in Patients With CAD

May 22, 2025 by
Will Chu, CRTonline.org

Research comparing paclitaxel and sirolimus-coated balloons (PCB and SCB), used in coronary artery disease (CAD) treatment, finds similar outcomes between the two balloons with respect to MACE at 2-years follow-up.

1-3 of 4225 results
1 2 3 4 5 Next »

Most Viewed Pages

Worse Patient Outcomes, Higher Costs in Waiting to Perform AVR in Patients With AS: Database Study

Outcomes of Complex, High-Risk PCI in Patients with Severe Aortic Stenosis: The ASCoP Registry

CMD Associated With Persistent Angina, Reduced Quality of Life in PCI Patients

Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?

Myval THV Still Non-Inferior to Sapien and Evolut at 1-Year in LANDMARK Study

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

BIOSTEMI Extended Survival: Orsiro DES Superior to Xience DES in STEMI Patients at 5 Years

Worse Patient Outcomes, Higher Costs in Waiting to Perform AVR in Patients With AS: Database Study

Coronary Function Testing Safe, Effective, Improves Quality of Life in ANOCA Patients: ILIAS-ANOCA Trial

Combined Registry Study Finds PCBs vs SCBs Demonstrate Similar 2-Year Outcomes in Patients With CAD

Most Viewed Pages

Explore the Site

Stay Connected